RecruitMe

Herbert Irving Comprehensive Cancer Center

Investigator

Daniel Lee, MD

212-317-5077

djl2164@cumc.columbia.edu

(Biography not available)

Clinical Studies Managed By This Investigator:

Condition	Study Title
Leukemia	[ CLOSED ] A study for patients with Relapsed or Refractory Acute Myeloid Leukemia (AML)
Leukemia	[ CLOSED ] A study for patients with acute myeloid leukemia using study drug Venetoclax in combination with Azacitidine
Leukemia	[ CLOSED ] Study of sertraline (Zoloft) with ara-C in combination in patients with acute myeloid leukemia (AML)
Leukemia	[ CLOSED ] Study of Drug in Patients with Acute Myeloid Leukemia (AML)
Leukemia	[ CLOSED ] Study of Alvocidib When Administered in Sequence After Decitabine in Patients with Myeolodysplastic Syndromes (MDS)
Leukemia	[ CLOSED ] A Study Evaluating the Safety and Pharmacokinetics of Atezolizumab Administered With Hu5F9-G4 to Patients With Acute Myeloid Leukemia
Leukemia	[ CLOSED ] A Study of MBG453 in Combination With Hypomethylating Agents in Subjects With Myelodysplastic Syndrome (MDS)
Leukemia	[ CLOSED ] Study of Alvocidib in Patients with Relapsed/Refractory Acute Myeloid Leukemia Following Treatment with Venetoclax Combination Therapy

This website uses cookies as well as similar tools and technologies to understand visitors’ experiences. By continuing to use this website, you consent to Columbia University’s usage of cookies and similar technologies, in accordance with the Columbia University Website Cookie Notice.

I AGREE